Indian ITC-HS · Tariff Item (8-digit)
HSN / HS Code 30069300Pharmaceutical Goods Specified in Note 4 to This Chapter — Placebos and blinded (or double-blinded) clinical trial kits for a recognised clinical trial, put up in measured doses DRUGS AND MEDICINES ARE SUPPLIED FREE OF COST TO THE PATIENTS UNDER THE PATIENT ASSISTANCE PROGRAMME OF THE SPECIFIED PHARMACEUTICAL COMPANY: [Notifn. No. 16/2017-Cus., dt. 20.4. 2017 as amended by 83/17, 41/20, 09/22, 07/24]. In exercise of the powers conferred by sub-section (1) of section 25 of the Customs Act, 1962 (52 of 1962), the Central Government, being satisfied that it is necessary in the public interest so to do, hereby exempts the goods, falling under Chapter 30 of the First Schedule to the Customs Tariff Act, 1975 (51 of 1975), of the description specified in column (2) of the Table below, for supply under Patient Assistance Programmes specified in the corresponding entry in column (3) of the said Table, run by the pharmaceutical companies specified in the corresponding entry in column (4) of the said Table, when imported into India, from the whole of the duty of customs leviable thereon which is specified in the First Schedule to the said Customs Tariff Act, subject to the following conditions, namely:- (a) the drugs and medicines are supplied free of cost to the patients under the Patient Assistance Programme of the specified pharmaceutical company; (b) the said pharmaceutical company furnishes an undertaking to the Assistant Commissioner of Customs or the Deputy Commissioner of Customs, as the case may be, having jurisdiction, to the effect that- (i) it shall maintain the following records:- (A) name, age, gender, residence and contact details of the patient; (B) copies of valid identity proof and residence proof of the patient and the caregiver, if any, as the case may be; (C) the disease diagnosed and the prescribed dosage of drugs and medicines; (D) the drugs and medicines imported or received and consumed under the said programme; (ii) the goods shall be used for the specified purpose only; (c) The said pharmaceutical company also furnishes an undertaking to the Assistant Commissioner of Customs or Deputy Commissioner of Customs, as the case may be, having jurisdiction, to pay, in the event of failure to comply with any of the aforesaid conditions, an amount equal to the duty leviable on such goods but for the exemption contained in this notification, along with the applicable interest thereon. TABLE Sr. Description of drug Name of Patient Name of No. / medicine Assistance Programme pharmaceutical company running Patient Assistance Programme 1. Xtandi (Enzulatamide) Xtandi Patient Assistance Programme Astellas Pharma India Pvt. Ltd. 2. Dasatinib (Sprycel) Sprycel Assistance Program Bristol Myers Squibb India Pvt. Ltd. 3. Nivolumab (Opdyta) OASIS Bristol Myers Squibb India Pvt. Ltd. 4. Halaven (Eribulin medylate) Hope to Her - Eisai Pharmaceuticals India Pvt. Soft Tissue Sarcoma free upto disease progression HELP - Eisai Pharmaceuticals India Pvt. All cycles free for below poverty Ltd. line patients 5. Zonegran (Zonisamide) - Livefree - 33% Eisai Pharmaceuticals India Pvt. for Epilespy Support to patients for extending Ltd. duration of treatment as this is a chronic therapy 6. Imbruvica 1+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 7. Zytiga 3+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 8. Velcade 1mg 3+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 9. Velcade 3.5 mg 1+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 10. Caelax 1+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 11. Dacogen 1+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 12. Yondelis 1+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 13. Simponi 1 vial free on 1st purchase Janssen India, Johnson & Johnson Pvt. Ltd. 14. Remicade 5+4 on 3 dose therapy, 6+6 on Janssen India, Johnson & 4 dose therapy Johnson Pvt. Ltd. 15. Invega all SKUs 1+1 PAP (Maintenance dosage) Janssen India, Johnson & Johnson Pvt. Ltd. 16. Imatinib (Glivec) Glivec NOA Program/ Glivec Novartis India Ltd. International PAP 17. Nilotinib (Tasigna) Win for Patients- Cancer Care/ Novartis Healthcare Private. Umaang Limited 18. Ruxolitinib (Jakavi) Win for Patients- Cancer Care/ Novartis Healthcare Private Umaang Limited 19. Everolimus (Afinitor) Win for Patients- Cancer Care/ Novartis Healthcare Private Umaang Limited 20. Ceritinib (Spexib) Win for Patients- Cancer Care/ Sandoz India Private Limited Umaang 21. Pazopanib (Votrient) Win for Patients- Cancer Care/ Novartis Healthcare Private Umaang Limited 22. Eltrombopag (Revolade) Win for Patients- Cancer Care/ Novartis Healthcare Private Umaang Limited 23. Indicaterol (Sequadra) Win for Patients - COPD Novartis India Ltd. 24. Secukinumab (Scapho) Win for Patients - Skincare Novartis India Ltd. 25. Omalizumab (Xolair CSU) Win for Patients - Skin care Novartis India Ltd. 26. Ranibizumab (Accentrix) Win for Patients - Visioncare Novartis India Ltd. 27. RITUXIMAB SPARSH - The Touch Dr. Reddy's Laboratories Ltd. 28. Erlotinib (Tarceva) The Blue Tree Roche Products (India) Private Limited 29. Trastuzumab (Herclon) The Blue Tree Roche Products (India) Private Limited 30. Pertuzumab (Perjeta) The Blue Tree Roche Products (India) Private Limited 31. Transtuzumab Emtansine The Blue Tree Roche Products (Kadcyla) (India) Private Limited 32. Obinutuzumab (Gazyva) The Blue Tree Roche Products (India) Private Limited 33. Bevacizumab (Avastin) The Blue Tree Roche Products (India) Private Limited 34. Tocilizumab (Actemra) Care for Joints Roche Products (India) Private Limited 35. Mycophenolate Aarambh Roche Products Mofetil (CellCept) (India) Private Limited 36. Avonex (Interferon Reach UCB India Private Limited Beta 1A) 37. Tysabri (Monoclonal Reach UCB India Private Limited Antibody 38. Tecfidera (Di-methyl Reach UCB India Private Limited Fumarate) 39. Plegridy (Peggylated Reach UCB India Private Limited Interferon Beta 1A) 40. Sorafenib (Nexavar) NexCSP (Nexavar Cancer Bayer ZydusPharma Private Survivorship Program) Limited 41. Sirturo (Bedaquiline) Bedaquiline Compassionate Janssen India, Johnson & Use Program Johnson Private Limited 42. Darzalex (Daratumumab) Daratumumab Patient Janssen India, Johnson & Assistance Program Johnson Private Limited 43. SUTENT Sutent Patient Assistance Programme - Pfizer Products India Private STAR Limited -Full subsidy for BPL patients 44. CRIZALK Crizalk Patient Assistance Programme- Pfizer Products India Private STAR Limited 45. INLYTA Inlyta Patient Assistance Programme - Pfizer Products India Private STAR Limited 46. PALBACE Palbace Patient Assistance Pfizer Products India Private Programme- PRERNA Limited 47. ENBREL Enbrel Patient Assistance Pfizer Limited 48. XELJANZ Xeljanz Patient Assistance Pfizer Limited 49. GENPTROPIN Genotropin Patient Assistance Pfizer Products India Private Programme Limited 50. Atgam Atgam Patient Assistance Programme Pfizer Products India Private Limited 51. Aromasin Aromasin Patient Assistance Pfizer Products India Private Programme Limited 52. Campto Campto Patient Assistance Programme Pfizer Products India Private Limited 1[53.Pembrolizumab Key- PAP 1.0 MSD Pharmaceuticals 54. Pembrolizumab KIRAN MSD Pharmaceuticals 55. Lorlatinib LorbriquaCare Pfizer Products India Private Ltd. 56. Dacomitinib DacoCare Pfizer Products India Private Ltd. 57. Inotuzumab Ozogamicin HemaCare Pfizer Products India Private Ltd. 58. Ribociclib UMAANG Novartis Healthcare Pvt. Ltd. 59. Dabrafenib UMAANG Novartis Healthcare Pvt. Ltd. 60. Selumetinib AstraZeneca Pharma PAP AstraZeneca Pharma India Limited 1 Inserted by Notification No. 09/2025 - Customs, dated 01.02.2025 w.e.f. 02.02.2025. 61. Benralizumab AstraZeneca Pharma PAP AstraZeneca Pharma India Limited 62. Fulvestrant AstraZeneca Pharma PAP AstraZeneca Pharma India Limited 63. Acalabrutinib AstraZeneca Pharma PAP AstraZeneca Pharma India Limited 64. Olaparib AstraZeneca Pharma PAP AstraZeneca Pharma India Limited 65. Amivantamab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 66. Teclistamab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 67. Ustekinumab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 68. Daratumumab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. And hyaluronidase-fihj 69. Ibrutinib Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 70. Bortezomib Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 71. Daratumumab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 72. Cetuximab Rainbow PAP Merck Specialties Pvt. Ltd. 73. Avelumab My Bavencio Assist Merck Specialties Pvt. Ltd. Program 74. Tepotinib My Tepmetko Patient Access Merck Specialties Pvt. Ltd. Program 75. Brentuximab Vedotin Takeda PAP Takeda Biopharmaceuticals India Pvt. Limited 76. Vedolizumab Takeda PAP Takeda Biopharmaceuticals India Pvt. Limited 77. Velaglucerase Alpha Takeda PAP Takeda Biopharmaceuticals India Pvt. Limited 78. Agalsidase Alpha Takeda PAP Takeda Biopharmaceuticals India Pvt. Limited 79. Idursulphase Takeda PAP Takeda Biopharmaceuticals India Pvt. Limited 80. Mepolizumab GSK Pharmaceuticals Limited GSK Pharmaceuticals Limited 81. Alectinib The Blue Tree Roche Products India Private Ltd. 82. Risdiplam Powder The Blue Tree Roche Products India Private Ltd. 83. Emicizumab The Blue Tree Roche Products India Private Ltd. 84. Atezolizumab The Blue Tree Roche Products India Private Ltd. 85. Pertuzumab + The Blue Tree Roche Products India Private trastuzumab Ltd. 86. Ocrelizumab The Blue Tree Roche Products India Private Ltd. 87. Polatuzumab vedotin The Blue Tree Roche Products India Private Ltd. 88. Faricimab The Blue Tree Roche Products India Private Ltd. 89. Luspatercept Bristol-Myers Patient Bristol-Myers Squibb India Pvt. Assistance Program Ltd.]
Why might this GST rate differ?
This is the base GST / IGST rate for the heading. The actual rate can vary with the product’s composition, form, packaging or end use — some sub-items attract a different rate under the schedules and exemptions of Notification 09/2025-Integrated Tax (Rate). Always verify the exact item before filing.
HSN code 30069300 covers Pharmaceutical Goods Specified in Note 4 to This Chapter — Placebos and blinded (or double-blinded) clinical trial kits for a recognised clinical trial, put up in measured doses DRUGS AND MEDICINES ARE SUPPLIED FREE OF COST TO THE PATIENTS UNDER THE PATIENT ASSISTANCE PROGRAMME OF THE SPECIFIED PHARMACEUTICAL COMPANY: [Notifn. No. 16/2017-Cus., dt. 20.4. 2017 as amended by 83/17, 41/20, 09/22, 07/24]. In exercise of the powers conferred by sub-section (1) of section 25 of the Customs Act, 1962 (52 of 1962), the Central Government, being satisfied that it is necessary in the public interest so to do, hereby exempts the goods, falling under Chapter 30 of the First Schedule to the Customs Tariff Act, 1975 (51 of 1975), of the description specified in column (2) of the Table below, for supply under Patient Assistance Programmes specified in the corresponding entry in column (3) of the said Table, run by the pharmaceutical companies specified in the corresponding entry in column (4) of the said Table, when imported into India, from the whole of the duty of customs leviable thereon which is specified in the First Schedule to the said Customs Tariff Act, subject to the following conditions, namely:- (a) the drugs and medicines are supplied free of cost to the patients under the Patient Assistance Programme of the specified pharmaceutical company; (b) the said pharmaceutical company furnishes an undertaking to the Assistant Commissioner of Customs or the Deputy Commissioner of Customs, as the case may be, having jurisdiction, to the effect that- (i) it shall maintain the following records:- (A) name, age, gender, residence and contact details of the patient; (B) copies of valid identity proof and residence proof of the patient and the caregiver, if any, as the case may be; (C) the disease diagnosed and the prescribed dosage of drugs and medicines; (D) the drugs and medicines imported or received and consumed under the said programme; (ii) the goods shall be used for the specified purpose only; (c) The said pharmaceutical company also furnishes an undertaking to the Assistant Commissioner of Customs or Deputy Commissioner of Customs, as the case may be, having jurisdiction, to pay, in the event of failure to comply with any of the aforesaid conditions, an amount equal to the duty leviable on such goods but for the exemption contained in this notification, along with the applicable interest thereon. TABLE Sr. Description of drug Name of Patient Name of No. / medicine Assistance Programme pharmaceutical company running Patient Assistance Programme 1. Xtandi (Enzulatamide) Xtandi Patient Assistance Programme Astellas Pharma India Pvt. Ltd. 2. Dasatinib (Sprycel) Sprycel Assistance Program Bristol Myers Squibb India Pvt. Ltd. 3. Nivolumab (Opdyta) OASIS Bristol Myers Squibb India Pvt. Ltd. 4. Halaven (Eribulin medylate) Hope to Her - Eisai Pharmaceuticals India Pvt. Soft Tissue Sarcoma free upto disease progression HELP - Eisai Pharmaceuticals India Pvt. All cycles free for below poverty Ltd. line patients 5. Zonegran (Zonisamide) - Livefree - 33% Eisai Pharmaceuticals India Pvt. for Epilespy Support to patients for extending Ltd. duration of treatment as this is a chronic therapy 6. Imbruvica 1+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 7. Zytiga 3+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 8. Velcade 1mg 3+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 9. Velcade 3.5 mg 1+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 10. Caelax 1+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 11. Dacogen 1+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 12. Yondelis 1+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 13. Simponi 1 vial free on 1st purchase Janssen India, Johnson & Johnson Pvt. Ltd. 14. Remicade 5+4 on 3 dose therapy, 6+6 on Janssen India, Johnson & 4 dose therapy Johnson Pvt. Ltd. 15. Invega all SKUs 1+1 PAP (Maintenance dosage) Janssen India, Johnson & Johnson Pvt. Ltd. 16. Imatinib (Glivec) Glivec NOA Program/ Glivec Novartis India Ltd. International PAP 17. Nilotinib (Tasigna) Win for Patients- Cancer Care/ Novartis Healthcare Private. Umaang Limited 18. Ruxolitinib (Jakavi) Win for Patients- Cancer Care/ Novartis Healthcare Private Umaang Limited 19. Everolimus (Afinitor) Win for Patients- Cancer Care/ Novartis Healthcare Private Umaang Limited 20. Ceritinib (Spexib) Win for Patients- Cancer Care/ Sandoz India Private Limited Umaang 21. Pazopanib (Votrient) Win for Patients- Cancer Care/ Novartis Healthcare Private Umaang Limited 22. Eltrombopag (Revolade) Win for Patients- Cancer Care/ Novartis Healthcare Private Umaang Limited 23. Indicaterol (Sequadra) Win for Patients - COPD Novartis India Ltd. 24. Secukinumab (Scapho) Win for Patients - Skincare Novartis India Ltd. 25. Omalizumab (Xolair CSU) Win for Patients - Skin care Novartis India Ltd. 26. Ranibizumab (Accentrix) Win for Patients - Visioncare Novartis India Ltd. 27. RITUXIMAB SPARSH - The Touch Dr. Reddy's Laboratories Ltd. 28. Erlotinib (Tarceva) The Blue Tree Roche Products (India) Private Limited 29. Trastuzumab (Herclon) The Blue Tree Roche Products (India) Private Limited 30. Pertuzumab (Perjeta) The Blue Tree Roche Products (India) Private Limited 31. Transtuzumab Emtansine The Blue Tree Roche Products (Kadcyla) (India) Private Limited 32. Obinutuzumab (Gazyva) The Blue Tree Roche Products (India) Private Limited 33. Bevacizumab (Avastin) The Blue Tree Roche Products (India) Private Limited 34. Tocilizumab (Actemra) Care for Joints Roche Products (India) Private Limited 35. Mycophenolate Aarambh Roche Products Mofetil (CellCept) (India) Private Limited 36. Avonex (Interferon Reach UCB India Private Limited Beta 1A) 37. Tysabri (Monoclonal Reach UCB India Private Limited Antibody 38. Tecfidera (Di-methyl Reach UCB India Private Limited Fumarate) 39. Plegridy (Peggylated Reach UCB India Private Limited Interferon Beta 1A) 40. Sorafenib (Nexavar) NexCSP (Nexavar Cancer Bayer ZydusPharma Private Survivorship Program) Limited 41. Sirturo (Bedaquiline) Bedaquiline Compassionate Janssen India, Johnson & Use Program Johnson Private Limited 42. Darzalex (Daratumumab) Daratumumab Patient Janssen India, Johnson & Assistance Program Johnson Private Limited 43. SUTENT Sutent Patient Assistance Programme - Pfizer Products India Private STAR Limited -Full subsidy for BPL patients 44. CRIZALK Crizalk Patient Assistance Programme- Pfizer Products India Private STAR Limited 45. INLYTA Inlyta Patient Assistance Programme - Pfizer Products India Private STAR Limited 46. PALBACE Palbace Patient Assistance Pfizer Products India Private Programme- PRERNA Limited 47. ENBREL Enbrel Patient Assistance Pfizer Limited 48. XELJANZ Xeljanz Patient Assistance Pfizer Limited 49. GENPTROPIN Genotropin Patient Assistance Pfizer Products India Private Programme Limited 50. Atgam Atgam Patient Assistance Programme Pfizer Products India Private Limited 51. Aromasin Aromasin Patient Assistance Pfizer Products India Private Programme Limited 52. Campto Campto Patient Assistance Programme Pfizer Products India Private Limited 1[53.Pembrolizumab Key- PAP 1.0 MSD Pharmaceuticals 54. Pembrolizumab KIRAN MSD Pharmaceuticals 55. Lorlatinib LorbriquaCare Pfizer Products India Private Ltd. 56. Dacomitinib DacoCare Pfizer Products India Private Ltd. 57. Inotuzumab Ozogamicin HemaCare Pfizer Products India Private Ltd. 58. Ribociclib UMAANG Novartis Healthcare Pvt. Ltd. 59. Dabrafenib UMAANG Novartis Healthcare Pvt. Ltd. 60. Selumetinib AstraZeneca Pharma PAP AstraZeneca Pharma India Limited 1 Inserted by Notification No. 09/2025 - Customs, dated 01.02.2025 w.e.f. 02.02.2025. 61. Benralizumab AstraZeneca Pharma PAP AstraZeneca Pharma India Limited 62. Fulvestrant AstraZeneca Pharma PAP AstraZeneca Pharma India Limited 63. Acalabrutinib AstraZeneca Pharma PAP AstraZeneca Pharma India Limited 64. Olaparib AstraZeneca Pharma PAP AstraZeneca Pharma India Limited 65. Amivantamab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 66. Teclistamab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 67. Ustekinumab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 68. Daratumumab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. And hyaluronidase-fihj 69. Ibrutinib Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 70. Bortezomib Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 71. Daratumumab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 72. Cetuximab Rainbow PAP Merck Specialties Pvt. Ltd. 73. Avelumab My Bavencio Assist Merck Specialties Pvt. Ltd. Program 74. Tepotinib My Tepmetko Patient Access Merck Specialties Pvt. Ltd. Program 75. Brentuximab Vedotin Takeda PAP Takeda Biopharmaceuticals India Pvt. Limited 76. Vedolizumab Takeda PAP Takeda Biopharmaceuticals India Pvt. Limited 77. Velaglucerase Alpha Takeda PAP Takeda Biopharmaceuticals India Pvt. Limited 78. Agalsidase Alpha Takeda PAP Takeda Biopharmaceuticals India Pvt. Limited 79. Idursulphase Takeda PAP Takeda Biopharmaceuticals India Pvt. Limited 80. Mepolizumab GSK Pharmaceuticals Limited GSK Pharmaceuticals Limited 81. Alectinib The Blue Tree Roche Products India Private Ltd. 82. Risdiplam Powder The Blue Tree Roche Products India Private Ltd. 83. Emicizumab The Blue Tree Roche Products India Private Ltd. 84. Atezolizumab The Blue Tree Roche Products India Private Ltd. 85. Pertuzumab + The Blue Tree Roche Products India Private trastuzumab Ltd. 86. Ocrelizumab The Blue Tree Roche Products India Private Ltd. 87. Polatuzumab vedotin The Blue Tree Roche Products India Private Ltd. 88. Faricimab The Blue Tree Roche Products India Private Ltd. 89. Luspatercept Bristol-Myers Patient Bristol-Myers Squibb India Pvt. Assistance Program Ltd.]. GST / IGST is 5%. Basic Customs Duty is 10%. Total effective import duty is about 17.71% on an assessable value of ₹100 (CIF).
Pharmaceutical Goods Specified in Note 4 to This Chapter — Placebos and blinded (or double-blinded) clinical trial kits for a recognised clinical trial, put up in measured doses DRUGS AND MEDICINES ARE SUPPLIED FREE OF COST TO THE PATIENTS UNDER THE PATIENT ASSISTANCE PROGRAMME OF THE SPECIFIED PHARMACEUTICAL COMPANY: [Notifn. No. 16/2017-Cus., dt. 20.4. 2017 as amended by 83/17, 41/20, 09/22, 07/24]. In exercise of the powers conferred by sub-section (1) of section 25 of the Customs Act, 1962 (52 of 1962), the Central Government, being satisfied that it is necessary in the public interest so to do, hereby exempts the goods, falling under Chapter 30 of the First Schedule to the Customs Tariff Act, 1975 (51 of 1975), of the description specified in column (2) of the Table below, for supply under Patient Assistance Programmes specified in the corresponding entry in column (3) of the said Table, run by the pharmaceutical companies specified in the corresponding entry in column (4) of the said Table, when imported into India, from the whole of the duty of customs leviable thereon which is specified in the First Schedule to the said Customs Tariff Act, subject to the following conditions, namely:- (a) the drugs and medicines are supplied free of cost to the patients under the Patient Assistance Programme of the specified pharmaceutical company; (b) the said pharmaceutical company furnishes an undertaking to the Assistant Commissioner of Customs or the Deputy Commissioner of Customs, as the case may be, having jurisdiction, to the effect that- (i) it shall maintain the following records:- (A) name, age, gender, residence and contact details of the patient; (B) copies of valid identity proof and residence proof of the patient and the caregiver, if any, as the case may be; (C) the disease diagnosed and the prescribed dosage of drugs and medicines; (D) the drugs and medicines imported or received and consumed under the said programme; (ii) the goods shall be used for the specified purpose only; (c) The said pharmaceutical company also furnishes an undertaking to the Assistant Commissioner of Customs or Deputy Commissioner of Customs, as the case may be, having jurisdiction, to pay, in the event of failure to comply with any of the aforesaid conditions, an amount equal to the duty leviable on such goods but for the exemption contained in this notification, along with the applicable interest thereon. TABLE Sr. Description of drug Name of Patient Name of No. / medicine Assistance Programme pharmaceutical company running Patient Assistance Programme 1. Xtandi (Enzulatamide) Xtandi Patient Assistance Programme Astellas Pharma India Pvt. Ltd. 2. Dasatinib (Sprycel) Sprycel Assistance Program Bristol Myers Squibb India Pvt. Ltd. 3. Nivolumab (Opdyta) OASIS Bristol Myers Squibb India Pvt. Ltd. 4. Halaven (Eribulin medylate) Hope to Her - Eisai Pharmaceuticals India Pvt. Soft Tissue Sarcoma free upto disease progression HELP - Eisai Pharmaceuticals India Pvt. All cycles free for below poverty Ltd. line patients 5. Zonegran (Zonisamide) - Livefree - 33% Eisai Pharmaceuticals India Pvt. for Epilespy Support to patients for extending Ltd. duration of treatment as this is a chronic therapy 6. Imbruvica 1+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 7. Zytiga 3+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 8. Velcade 1mg 3+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 9. Velcade 3.5 mg 1+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 10. Caelax 1+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 11. Dacogen 1+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 12. Yondelis 1+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 13. Simponi 1 vial free on 1st purchase Janssen India, Johnson & Johnson Pvt. Ltd. 14. Remicade 5+4 on 3 dose therapy, 6+6 on Janssen India, Johnson & 4 dose therapy Johnson Pvt. Ltd. 15. Invega all SKUs 1+1 PAP (Maintenance dosage) Janssen India, Johnson & Johnson Pvt. Ltd. 16. Imatinib (Glivec) Glivec NOA Program/ Glivec Novartis India Ltd. International PAP 17. Nilotinib (Tasigna) Win for Patients- Cancer Care/ Novartis Healthcare Private. Umaang Limited 18. Ruxolitinib (Jakavi) Win for Patients- Cancer Care/ Novartis Healthcare Private Umaang Limited 19. Everolimus (Afinitor) Win for Patients- Cancer Care/ Novartis Healthcare Private Umaang Limited 20. Ceritinib (Spexib) Win for Patients- Cancer Care/ Sandoz India Private Limited Umaang 21. Pazopanib (Votrient) Win for Patients- Cancer Care/ Novartis Healthcare Private Umaang Limited 22. Eltrombopag (Revolade) Win for Patients- Cancer Care/ Novartis Healthcare Private Umaang Limited 23. Indicaterol (Sequadra) Win for Patients - COPD Novartis India Ltd. 24. Secukinumab (Scapho) Win for Patients - Skincare Novartis India Ltd. 25. Omalizumab (Xolair CSU) Win for Patients - Skin care Novartis India Ltd. 26. Ranibizumab (Accentrix) Win for Patients - Visioncare Novartis India Ltd. 27. RITUXIMAB SPARSH - The Touch Dr. Reddy's Laboratories Ltd. 28. Erlotinib (Tarceva) The Blue Tree Roche Products (India) Private Limited 29. Trastuzumab (Herclon) The Blue Tree Roche Products (India) Private Limited 30. Pertuzumab (Perjeta) The Blue Tree Roche Products (India) Private Limited 31. Transtuzumab Emtansine The Blue Tree Roche Products (Kadcyla) (India) Private Limited 32. Obinutuzumab (Gazyva) The Blue Tree Roche Products (India) Private Limited 33. Bevacizumab (Avastin) The Blue Tree Roche Products (India) Private Limited 34. Tocilizumab (Actemra) Care for Joints Roche Products (India) Private Limited 35. Mycophenolate Aarambh Roche Products Mofetil (CellCept) (India) Private Limited 36. Avonex (Interferon Reach UCB India Private Limited Beta 1A) 37. Tysabri (Monoclonal Reach UCB India Private Limited Antibody 38. Tecfidera (Di-methyl Reach UCB India Private Limited Fumarate) 39. Plegridy (Peggylated Reach UCB India Private Limited Interferon Beta 1A) 40. Sorafenib (Nexavar) NexCSP (Nexavar Cancer Bayer ZydusPharma Private Survivorship Program) Limited 41. Sirturo (Bedaquiline) Bedaquiline Compassionate Janssen India, Johnson & Use Program Johnson Private Limited 42. Darzalex (Daratumumab) Daratumumab Patient Janssen India, Johnson & Assistance Program Johnson Private Limited 43. SUTENT Sutent Patient Assistance Programme - Pfizer Products India Private STAR Limited -Full subsidy for BPL patients 44. CRIZALK Crizalk Patient Assistance Programme- Pfizer Products India Private STAR Limited 45. INLYTA Inlyta Patient Assistance Programme - Pfizer Products India Private STAR Limited 46. PALBACE Palbace Patient Assistance Pfizer Products India Private Programme- PRERNA Limited 47. ENBREL Enbrel Patient Assistance Pfizer Limited 48. XELJANZ Xeljanz Patient Assistance Pfizer Limited 49. GENPTROPIN Genotropin Patient Assistance Pfizer Products India Private Programme Limited 50. Atgam Atgam Patient Assistance Programme Pfizer Products India Private Limited 51. Aromasin Aromasin Patient Assistance Pfizer Products India Private Programme Limited 52. Campto Campto Patient Assistance Programme Pfizer Products India Private Limited 1[53.Pembrolizumab Key- PAP 1.0 MSD Pharmaceuticals 54. Pembrolizumab KIRAN MSD Pharmaceuticals 55. Lorlatinib LorbriquaCare Pfizer Products India Private Ltd. 56. Dacomitinib DacoCare Pfizer Products India Private Ltd. 57. Inotuzumab Ozogamicin HemaCare Pfizer Products India Private Ltd. 58. Ribociclib UMAANG Novartis Healthcare Pvt. Ltd. 59. Dabrafenib UMAANG Novartis Healthcare Pvt. Ltd. 60. Selumetinib AstraZeneca Pharma PAP AstraZeneca Pharma India Limited 1 Inserted by Notification No. 09/2025 - Customs, dated 01.02.2025 w.e.f. 02.02.2025. 61. Benralizumab AstraZeneca Pharma PAP AstraZeneca Pharma India Limited 62. Fulvestrant AstraZeneca Pharma PAP AstraZeneca Pharma India Limited 63. Acalabrutinib AstraZeneca Pharma PAP AstraZeneca Pharma India Limited 64. Olaparib AstraZeneca Pharma PAP AstraZeneca Pharma India Limited 65. Amivantamab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 66. Teclistamab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 67. Ustekinumab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 68. Daratumumab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. And hyaluronidase-fihj 69. Ibrutinib Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 70. Bortezomib Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 71. Daratumumab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 72. Cetuximab Rainbow PAP Merck Specialties Pvt. Ltd. 73. Avelumab My Bavencio Assist Merck Specialties Pvt. Ltd. Program 74. Tepotinib My Tepmetko Patient Access Merck Specialties Pvt. Ltd. Program 75. Brentuximab Vedotin Takeda PAP Takeda Biopharmaceuticals India Pvt. Limited 76. Vedolizumab Takeda PAP Takeda Biopharmaceuticals India Pvt. Limited 77. Velaglucerase Alpha Takeda PAP Takeda Biopharmaceuticals India Pvt. Limited 78. Agalsidase Alpha Takeda PAP Takeda Biopharmaceuticals India Pvt. Limited 79. Idursulphase Takeda PAP Takeda Biopharmaceuticals India Pvt. Limited 80. Mepolizumab GSK Pharmaceuticals Limited GSK Pharmaceuticals Limited 81. Alectinib The Blue Tree Roche Products India Private Ltd. 82. Risdiplam Powder The Blue Tree Roche Products India Private Ltd. 83. Emicizumab The Blue Tree Roche Products India Private Ltd. 84. Atezolizumab The Blue Tree Roche Products India Private Ltd. 85. Pertuzumab + The Blue Tree Roche Products India Private trastuzumab Ltd. 86. Ocrelizumab The Blue Tree Roche Products India Private Ltd. 87. Polatuzumab vedotin The Blue Tree Roche Products India Private Ltd. 88. Faricimab The Blue Tree Roche Products India Private Ltd. 89. Luspatercept Bristol-Myers Patient Bristol-Myers Squibb India Pvt. Assistance Program Ltd.]
Importing this at the standard rate costs ≈ ₹17.7 in duty for every ₹100 of shipment value.
What will my shipment cost to land?
Enter your actual shipment value and where you're buying from. We compute the duty on top — the same stack customs applies at the port. Figures are indicative; verify on ICEGATE before filing.
Compliance at a glance
Effective import duty stack
Live values from India's ICEGATE customs calculator, computed on an assessable value of ₹100.
Unit of measure: kg.
| Component | Rate | Amount / ₹100 |
|---|---|---|
BCDBasic Customs Duty — the headline tariff rate from the First Schedule. | 10% | ₹10.00 |
AIDCAgriculture Infrastructure & Development Cess — calculated on BCD. | 10% | ₹1.00 |
SWSSocial Welfare Surcharge — calculated on (BCD + AIDC). | 10% | ₹1.10 |
IGSTIntegrated Goods and Services Tax — on (CIF + BCD + AIDC + SWS). | 5% | ₹5.61 |
| Total Duty | 17.71% | ≈ ₹17.71 / ₹100 CIF |
For an assessable value of ₹100:
- BCD = AV × 10% = ₹10.00
- AIDC = BCD × 10% = ₹1.00
- SWS = (BCD + AIDC) × 10% = ₹1.10(exemption notifications exist for this code; verify eligibility)
- IGST = (AV + BCD + AIDC + SWS) × 5% = ₹5.61
- Total Duty = BCD + AIDC + SWS + IGST = ₹17.71 (17.71%)
Notifications and exemptions can lower the effective rate for specific goods or FTA partner countries. Cross-check against the latest CBIC circulars before filing.
Where to source to pay less
Basic Customs Duty under each Free Trade Agreement, sorted by best rate. Other duties (AIDC, SWS, IGST) still apply on top.
- Least Developed CountriesBest rate0%save 10pp
- Nepal0%save 10pp
- SAFTA (LDC) countries0%save 10pp
- Sri Lanka0%save 10pp
- SAFTA countries5%save 5pp
- MFN — no FTA (baseline)10%standard rate
Source: ITC MACMAP. Eligibility depends on Rules of Origin — consult the relevant FTA notification before filing.
Ask AI about this code
Answers are grounded in the official tariff data shown on this page.
AI-generated from official tariff data on this page, and may use web search for added context. Indicative only — verify duties and compliance against the latest CBIC/DGFT notifications before importing.
Where this code sits
- 1
- 230069300Tariff Item (8-digit)Placebos and blinded (or double-blinded) clinical trial kits for a recognised clinical trial, put up in measured doses DRUGS AND MEDICINES ARE SUPPLIED FREE OF COST TO THE PATIENTS UNDER THE PATIENT ASSISTANCE PROGRAMME OF THE SPECIFIED PHARMACEUTICAL COMPANY: [Notifn. No. 16/2017-Cus., dt. 20.4. 2017 as amended by 83/17, 41/20, 09/22, 07/24]. In exercise of the powers conferred by sub-section (1) of section 25 of the Customs Act, 1962 (52 of 1962), the Central Government, being satisfied that it is necessary in the public interest so to do, hereby exempts the goods, falling under Chapter 30 of the First Schedule to the Customs Tariff Act, 1975 (51 of 1975), of the description specified in column (2) of the Table below, for supply under Patient Assistance Programmes specified in the corresponding entry in column (3) of the said Table, run by the pharmaceutical companies specified in the corresponding entry in column (4) of the said Table, when imported into India, from the whole of the duty of customs leviable thereon which is specified in the First Schedule to the said Customs Tariff Act, subject to the following conditions, namely:- (a) the drugs and medicines are supplied free of cost to the patients under the Patient Assistance Programme of the specified pharmaceutical company; (b) the said pharmaceutical company furnishes an undertaking to the Assistant Commissioner of Customs or the Deputy Commissioner of Customs, as the case may be, having jurisdiction, to the effect that- (i) it shall maintain the following records:- (A) name, age, gender, residence and contact details of the patient; (B) copies of valid identity proof and residence proof of the patient and the caregiver, if any, as the case may be; (C) the disease diagnosed and the prescribed dosage of drugs and medicines; (D) the drugs and medicines imported or received and consumed under the said programme; (ii) the goods shall be used for the specified purpose only; (c) The said pharmaceutical company also furnishes an undertaking to the Assistant Commissioner of Customs or Deputy Commissioner of Customs, as the case may be, having jurisdiction, to pay, in the event of failure to comply with any of the aforesaid conditions, an amount equal to the duty leviable on such goods but for the exemption contained in this notification, along with the applicable interest thereon. TABLE Sr. Description of drug Name of Patient Name of No. / medicine Assistance Programme pharmaceutical company running Patient Assistance Programme 1. Xtandi (Enzulatamide) Xtandi Patient Assistance Programme Astellas Pharma India Pvt. Ltd. 2. Dasatinib (Sprycel) Sprycel Assistance Program Bristol Myers Squibb India Pvt. Ltd. 3. Nivolumab (Opdyta) OASIS Bristol Myers Squibb India Pvt. Ltd. 4. Halaven (Eribulin medylate) Hope to Her - Eisai Pharmaceuticals India Pvt. Soft Tissue Sarcoma free upto disease progression HELP - Eisai Pharmaceuticals India Pvt. All cycles free for below poverty Ltd. line patients 5. Zonegran (Zonisamide) - Livefree - 33% Eisai Pharmaceuticals India Pvt. for Epilespy Support to patients for extending Ltd. duration of treatment as this is a chronic therapy 6. Imbruvica 1+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 7. Zytiga 3+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 8. Velcade 1mg 3+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 9. Velcade 3.5 mg 1+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 10. Caelax 1+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 11. Dacogen 1+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 12. Yondelis 1+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 13. Simponi 1 vial free on 1st purchase Janssen India, Johnson & Johnson Pvt. Ltd. 14. Remicade 5+4 on 3 dose therapy, 6+6 on Janssen India, Johnson & 4 dose therapy Johnson Pvt. Ltd. 15. Invega all SKUs 1+1 PAP (Maintenance dosage) Janssen India, Johnson & Johnson Pvt. Ltd. 16. Imatinib (Glivec) Glivec NOA Program/ Glivec Novartis India Ltd. International PAP 17. Nilotinib (Tasigna) Win for Patients- Cancer Care/ Novartis Healthcare Private. Umaang Limited 18. Ruxolitinib (Jakavi) Win for Patients- Cancer Care/ Novartis Healthcare Private Umaang Limited 19. Everolimus (Afinitor) Win for Patients- Cancer Care/ Novartis Healthcare Private Umaang Limited 20. Ceritinib (Spexib) Win for Patients- Cancer Care/ Sandoz India Private Limited Umaang 21. Pazopanib (Votrient) Win for Patients- Cancer Care/ Novartis Healthcare Private Umaang Limited 22. Eltrombopag (Revolade) Win for Patients- Cancer Care/ Novartis Healthcare Private Umaang Limited 23. Indicaterol (Sequadra) Win for Patients - COPD Novartis India Ltd. 24. Secukinumab (Scapho) Win for Patients - Skincare Novartis India Ltd. 25. Omalizumab (Xolair CSU) Win for Patients - Skin care Novartis India Ltd. 26. Ranibizumab (Accentrix) Win for Patients - Visioncare Novartis India Ltd. 27. RITUXIMAB SPARSH - The Touch Dr. Reddy's Laboratories Ltd. 28. Erlotinib (Tarceva) The Blue Tree Roche Products (India) Private Limited 29. Trastuzumab (Herclon) The Blue Tree Roche Products (India) Private Limited 30. Pertuzumab (Perjeta) The Blue Tree Roche Products (India) Private Limited 31. Transtuzumab Emtansine The Blue Tree Roche Products (Kadcyla) (India) Private Limited 32. Obinutuzumab (Gazyva) The Blue Tree Roche Products (India) Private Limited 33. Bevacizumab (Avastin) The Blue Tree Roche Products (India) Private Limited 34. Tocilizumab (Actemra) Care for Joints Roche Products (India) Private Limited 35. Mycophenolate Aarambh Roche Products Mofetil (CellCept) (India) Private Limited 36. Avonex (Interferon Reach UCB India Private Limited Beta 1A) 37. Tysabri (Monoclonal Reach UCB India Private Limited Antibody 38. Tecfidera (Di-methyl Reach UCB India Private Limited Fumarate) 39. Plegridy (Peggylated Reach UCB India Private Limited Interferon Beta 1A) 40. Sorafenib (Nexavar) NexCSP (Nexavar Cancer Bayer ZydusPharma Private Survivorship Program) Limited 41. Sirturo (Bedaquiline) Bedaquiline Compassionate Janssen India, Johnson & Use Program Johnson Private Limited 42. Darzalex (Daratumumab) Daratumumab Patient Janssen India, Johnson & Assistance Program Johnson Private Limited 43. SUTENT Sutent Patient Assistance Programme - Pfizer Products India Private STAR Limited -Full subsidy for BPL patients 44. CRIZALK Crizalk Patient Assistance Programme- Pfizer Products India Private STAR Limited 45. INLYTA Inlyta Patient Assistance Programme - Pfizer Products India Private STAR Limited 46. PALBACE Palbace Patient Assistance Pfizer Products India Private Programme- PRERNA Limited 47. ENBREL Enbrel Patient Assistance Pfizer Limited 48. XELJANZ Xeljanz Patient Assistance Pfizer Limited 49. GENPTROPIN Genotropin Patient Assistance Pfizer Products India Private Programme Limited 50. Atgam Atgam Patient Assistance Programme Pfizer Products India Private Limited 51. Aromasin Aromasin Patient Assistance Pfizer Products India Private Programme Limited 52. Campto Campto Patient Assistance Programme Pfizer Products India Private Limited 1[53.Pembrolizumab Key- PAP 1.0 MSD Pharmaceuticals 54. Pembrolizumab KIRAN MSD Pharmaceuticals 55. Lorlatinib LorbriquaCare Pfizer Products India Private Ltd. 56. Dacomitinib DacoCare Pfizer Products India Private Ltd. 57. Inotuzumab Ozogamicin HemaCare Pfizer Products India Private Ltd. 58. Ribociclib UMAANG Novartis Healthcare Pvt. Ltd. 59. Dabrafenib UMAANG Novartis Healthcare Pvt. Ltd. 60. Selumetinib AstraZeneca Pharma PAP AstraZeneca Pharma India Limited 1 Inserted by Notification No. 09/2025 - Customs, dated 01.02.2025 w.e.f. 02.02.2025. 61. Benralizumab AstraZeneca Pharma PAP AstraZeneca Pharma India Limited 62. Fulvestrant AstraZeneca Pharma PAP AstraZeneca Pharma India Limited 63. Acalabrutinib AstraZeneca Pharma PAP AstraZeneca Pharma India Limited 64. Olaparib AstraZeneca Pharma PAP AstraZeneca Pharma India Limited 65. Amivantamab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 66. Teclistamab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 67. Ustekinumab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 68. Daratumumab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. And hyaluronidase-fihj 69. Ibrutinib Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 70. Bortezomib Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 71. Daratumumab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 72. Cetuximab Rainbow PAP Merck Specialties Pvt. Ltd. 73. Avelumab My Bavencio Assist Merck Specialties Pvt. Ltd. Program 74. Tepotinib My Tepmetko Patient Access Merck Specialties Pvt. Ltd. Program 75. Brentuximab Vedotin Takeda PAP Takeda Biopharmaceuticals India Pvt. Limited 76. Vedolizumab Takeda PAP Takeda Biopharmaceuticals India Pvt. Limited 77. Velaglucerase Alpha Takeda PAP Takeda Biopharmaceuticals India Pvt. Limited 78. Agalsidase Alpha Takeda PAP Takeda Biopharmaceuticals India Pvt. Limited 79. Idursulphase Takeda PAP Takeda Biopharmaceuticals India Pvt. Limited 80. Mepolizumab GSK Pharmaceuticals Limited GSK Pharmaceuticals Limited 81. Alectinib The Blue Tree Roche Products India Private Ltd. 82. Risdiplam Powder The Blue Tree Roche Products India Private Ltd. 83. Emicizumab The Blue Tree Roche Products India Private Ltd. 84. Atezolizumab The Blue Tree Roche Products India Private Ltd. 85. Pertuzumab + The Blue Tree Roche Products India Private trastuzumab Ltd. 86. Ocrelizumab The Blue Tree Roche Products India Private Ltd. 87. Polatuzumab vedotin The Blue Tree Roche Products India Private Ltd. 88. Faricimab The Blue Tree Roche Products India Private Ltd. 89. Luspatercept Bristol-Myers Patient Bristol-Myers Squibb India Pvt. Assistance Program Ltd.]
Other HSN codes in heading 3006
Related 8-digit tariff items you may be looking for instead.
- 30061010Sterile, surgical catgut and similar sterile suture materials (including sterile absorbable surgical or dental yarns) and sterile tissue adhesives for wound closure
- 30061020Sterile laminaria and sterile laminaria tents, sterile absorbable surgical or dental haemostatics, sterile surgical or dental adhesion barriers, whether or not absorbable
- 30062000Omitted
- 30063000Opacifying preprations for X-ray examinations; diagnostic kg. 10% - reagents designed to be administered to the patient
- 30064000Dental cements and other dental fillings; bone reconstruction cements
- 30065000First-aid boxes and kits
- 30066010Based on hormones
- 30066020Based on other products of heading
- 30066030Based on spermicides
- 30067000Gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments
- 30069100Appliances identifiable for ostomy use
- 30069200Waste pharmaceuticals 10% -
What is an HSN Code?
An HSN code (Harmonized System of Nomenclature) is an internationally standardised numeric system to classify traded products. Indian customs extend it to an 8-digit ITC-HS code for more precise classification, taxation and compliance.
- First 2 digits: Chapter (e.g. 30)
- Digits 3–4: Heading
- Digits 5–6: Subheading (WCO-aligned)
- Last 2 digits: Indian ITC extension for added granularity
Why is the right HSN code important?
- Ensures correct calculation of customs duties and taxes.
- Required for shipping bills, bills of entry, GST filings and FTA certificates of origin.
- Helps avoid clearance delays, penalties or reclassification disputes.
How to use this HSN code
Export Documentation
Use this code in your Commercial Invoice, Packing List, and Shipping Bill for exports from India.
Import Clearance
Required for the Bill of Entry and customs clearance when importing goods into India.
GST Classification
Drives the applicable GST rate, HSN-wise summary in GSTR-1 and ITC eligibility checks.
Common HSN code mistakes to avoid
- • Reusing outdated or incorrect codes from old shipments
- • Mixing up similar product codes without checking descriptions
- • Ignoring the last 2 digits which affect Indian duty rates
- • Not considering composition, end use or manufacturing process
- • Relying solely on online tools without professional verification
Need more information?
For complex products, consult with customs brokers or trade experts who can classify based on:
- • Physical product inspection
- • Material composition / manufacturing process
- • Intended end-use
- • Latest customs notifications & advance rulings
Additional Resources
• DGFT Policy: Guidelines for export-import procedures
• Customs Tariff: Complete HSN code list with duty rates
• GST Notifications: Latest tax-rate updates
• Trade Portal: Government trade documentation support
Related EximPe tools
Free, no signup — same trade-and-payments toolset your team uses to move money across borders.
Import Duty Calculator
BCD, IGST, cess and total landed cost for any HSN code — MFN and FTA rates.
Open toolSWIFT Code Finder
Verify SWIFT/BIC codes for global bank transfers. By country, city, or bank.
Open toolCurrency Converter
Live mid-market FX rates for 150+ currencies. Inbound INR conversions for exporters.
Open toolInvoice Generator
Build a cross-border invoice in minutes. Edit fields inline, export to PDF.
Open toolHSN Code 30069300 — FAQs
Duty, GST and classification questions answered from the official Customs Tariff data.
HSN code 30069300 (Pharmaceutical Goods Specified in Note 4 to This Chapter — Placebos and blinded (or double-blinded) clinical trial kits for a recognised clinical trial, put up in measured doses DRUGS AND MEDICINES ARE SUPPLIED FREE OF COST TO THE PATIENTS UNDER THE PATIENT ASSISTANCE PROGRAMME OF THE SPECIFIED PHARMACEUTICAL COMPANY: [Notifn. No. 16/2017-Cus., dt. 20.4. 2017 as amended by 83/17, 41/20, 09/22, 07/24]. In exercise of the powers conferred by sub-section (1) of section 25 of the Customs Act, 1962 (52 of 1962), the Central Government, being satisfied that it is necessary in the public interest so to do, hereby exempts the goods, falling under Chapter 30 of the First Schedule to the Customs Tariff Act, 1975 (51 of 1975), of the description specified in column (2) of the Table below, for supply under Patient Assistance Programmes specified in the corresponding entry in column (3) of the said Table, run by the pharmaceutical companies specified in the corresponding entry in column (4) of the said Table, when imported into India, from the whole of the duty of customs leviable thereon which is specified in the First Schedule to the said Customs Tariff Act, subject to the following conditions, namely:- (a) the drugs and medicines are supplied free of cost to the patients under the Patient Assistance Programme of the specified pharmaceutical company; (b) the said pharmaceutical company furnishes an undertaking to the Assistant Commissioner of Customs or the Deputy Commissioner of Customs, as the case may be, having jurisdiction, to the effect that- (i) it shall maintain the following records:- (A) name, age, gender, residence and contact details of the patient; (B) copies of valid identity proof and residence proof of the patient and the caregiver, if any, as the case may be; (C) the disease diagnosed and the prescribed dosage of drugs and medicines; (D) the drugs and medicines imported or received and consumed under the said programme; (ii) the goods shall be used for the specified purpose only; (c) The said pharmaceutical company also furnishes an undertaking to the Assistant Commissioner of Customs or Deputy Commissioner of Customs, as the case may be, having jurisdiction, to pay, in the event of failure to comply with any of the aforesaid conditions, an amount equal to the duty leviable on such goods but for the exemption contained in this notification, along with the applicable interest thereon. TABLE Sr. Description of drug Name of Patient Name of No. / medicine Assistance Programme pharmaceutical company running Patient Assistance Programme 1. Xtandi (Enzulatamide) Xtandi Patient Assistance Programme Astellas Pharma India Pvt. Ltd. 2. Dasatinib (Sprycel) Sprycel Assistance Program Bristol Myers Squibb India Pvt. Ltd. 3. Nivolumab (Opdyta) OASIS Bristol Myers Squibb India Pvt. Ltd. 4. Halaven (Eribulin medylate) Hope to Her - Eisai Pharmaceuticals India Pvt. Soft Tissue Sarcoma free upto disease progression HELP - Eisai Pharmaceuticals India Pvt. All cycles free for below poverty Ltd. line patients 5. Zonegran (Zonisamide) - Livefree - 33% Eisai Pharmaceuticals India Pvt. for Epilespy Support to patients for extending Ltd. duration of treatment as this is a chronic therapy 6. Imbruvica 1+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 7. Zytiga 3+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 8. Velcade 1mg 3+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 9. Velcade 3.5 mg 1+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 10. Caelax 1+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 11. Dacogen 1+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 12. Yondelis 1+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 13. Simponi 1 vial free on 1st purchase Janssen India, Johnson & Johnson Pvt. Ltd. 14. Remicade 5+4 on 3 dose therapy, 6+6 on Janssen India, Johnson & 4 dose therapy Johnson Pvt. Ltd. 15. Invega all SKUs 1+1 PAP (Maintenance dosage) Janssen India, Johnson & Johnson Pvt. Ltd. 16. Imatinib (Glivec) Glivec NOA Program/ Glivec Novartis India Ltd. International PAP 17. Nilotinib (Tasigna) Win for Patients- Cancer Care/ Novartis Healthcare Private. Umaang Limited 18. Ruxolitinib (Jakavi) Win for Patients- Cancer Care/ Novartis Healthcare Private Umaang Limited 19. Everolimus (Afinitor) Win for Patients- Cancer Care/ Novartis Healthcare Private Umaang Limited 20. Ceritinib (Spexib) Win for Patients- Cancer Care/ Sandoz India Private Limited Umaang 21. Pazopanib (Votrient) Win for Patients- Cancer Care/ Novartis Healthcare Private Umaang Limited 22. Eltrombopag (Revolade) Win for Patients- Cancer Care/ Novartis Healthcare Private Umaang Limited 23. Indicaterol (Sequadra) Win for Patients - COPD Novartis India Ltd. 24. Secukinumab (Scapho) Win for Patients - Skincare Novartis India Ltd. 25. Omalizumab (Xolair CSU) Win for Patients - Skin care Novartis India Ltd. 26. Ranibizumab (Accentrix) Win for Patients - Visioncare Novartis India Ltd. 27. RITUXIMAB SPARSH - The Touch Dr. Reddy's Laboratories Ltd. 28. Erlotinib (Tarceva) The Blue Tree Roche Products (India) Private Limited 29. Trastuzumab (Herclon) The Blue Tree Roche Products (India) Private Limited 30. Pertuzumab (Perjeta) The Blue Tree Roche Products (India) Private Limited 31. Transtuzumab Emtansine The Blue Tree Roche Products (Kadcyla) (India) Private Limited 32. Obinutuzumab (Gazyva) The Blue Tree Roche Products (India) Private Limited 33. Bevacizumab (Avastin) The Blue Tree Roche Products (India) Private Limited 34. Tocilizumab (Actemra) Care for Joints Roche Products (India) Private Limited 35. Mycophenolate Aarambh Roche Products Mofetil (CellCept) (India) Private Limited 36. Avonex (Interferon Reach UCB India Private Limited Beta 1A) 37. Tysabri (Monoclonal Reach UCB India Private Limited Antibody 38. Tecfidera (Di-methyl Reach UCB India Private Limited Fumarate) 39. Plegridy (Peggylated Reach UCB India Private Limited Interferon Beta 1A) 40. Sorafenib (Nexavar) NexCSP (Nexavar Cancer Bayer ZydusPharma Private Survivorship Program) Limited 41. Sirturo (Bedaquiline) Bedaquiline Compassionate Janssen India, Johnson & Use Program Johnson Private Limited 42. Darzalex (Daratumumab) Daratumumab Patient Janssen India, Johnson & Assistance Program Johnson Private Limited 43. SUTENT Sutent Patient Assistance Programme - Pfizer Products India Private STAR Limited -Full subsidy for BPL patients 44. CRIZALK Crizalk Patient Assistance Programme- Pfizer Products India Private STAR Limited 45. INLYTA Inlyta Patient Assistance Programme - Pfizer Products India Private STAR Limited 46. PALBACE Palbace Patient Assistance Pfizer Products India Private Programme- PRERNA Limited 47. ENBREL Enbrel Patient Assistance Pfizer Limited 48. XELJANZ Xeljanz Patient Assistance Pfizer Limited 49. GENPTROPIN Genotropin Patient Assistance Pfizer Products India Private Programme Limited 50. Atgam Atgam Patient Assistance Programme Pfizer Products India Private Limited 51. Aromasin Aromasin Patient Assistance Pfizer Products India Private Programme Limited 52. Campto Campto Patient Assistance Programme Pfizer Products India Private Limited 1[53.Pembrolizumab Key- PAP 1.0 MSD Pharmaceuticals 54. Pembrolizumab KIRAN MSD Pharmaceuticals 55. Lorlatinib LorbriquaCare Pfizer Products India Private Ltd. 56. Dacomitinib DacoCare Pfizer Products India Private Ltd. 57. Inotuzumab Ozogamicin HemaCare Pfizer Products India Private Ltd. 58. Ribociclib UMAANG Novartis Healthcare Pvt. Ltd. 59. Dabrafenib UMAANG Novartis Healthcare Pvt. Ltd. 60. Selumetinib AstraZeneca Pharma PAP AstraZeneca Pharma India Limited 1 Inserted by Notification No. 09/2025 - Customs, dated 01.02.2025 w.e.f. 02.02.2025. 61. Benralizumab AstraZeneca Pharma PAP AstraZeneca Pharma India Limited 62. Fulvestrant AstraZeneca Pharma PAP AstraZeneca Pharma India Limited 63. Acalabrutinib AstraZeneca Pharma PAP AstraZeneca Pharma India Limited 64. Olaparib AstraZeneca Pharma PAP AstraZeneca Pharma India Limited 65. Amivantamab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 66. Teclistamab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 67. Ustekinumab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 68. Daratumumab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. And hyaluronidase-fihj 69. Ibrutinib Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 70. Bortezomib Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 71. Daratumumab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 72. Cetuximab Rainbow PAP Merck Specialties Pvt. Ltd. 73. Avelumab My Bavencio Assist Merck Specialties Pvt. Ltd. Program 74. Tepotinib My Tepmetko Patient Access Merck Specialties Pvt. Ltd. Program 75. Brentuximab Vedotin Takeda PAP Takeda Biopharmaceuticals India Pvt. Limited 76. Vedolizumab Takeda PAP Takeda Biopharmaceuticals India Pvt. Limited 77. Velaglucerase Alpha Takeda PAP Takeda Biopharmaceuticals India Pvt. Limited 78. Agalsidase Alpha Takeda PAP Takeda Biopharmaceuticals India Pvt. Limited 79. Idursulphase Takeda PAP Takeda Biopharmaceuticals India Pvt. Limited 80. Mepolizumab GSK Pharmaceuticals Limited GSK Pharmaceuticals Limited 81. Alectinib The Blue Tree Roche Products India Private Ltd. 82. Risdiplam Powder The Blue Tree Roche Products India Private Ltd. 83. Emicizumab The Blue Tree Roche Products India Private Ltd. 84. Atezolizumab The Blue Tree Roche Products India Private Ltd. 85. Pertuzumab + The Blue Tree Roche Products India Private trastuzumab Ltd. 86. Ocrelizumab The Blue Tree Roche Products India Private Ltd. 87. Polatuzumab vedotin The Blue Tree Roche Products India Private Ltd. 88. Faricimab The Blue Tree Roche Products India Private Ltd. 89. Luspatercept Bristol-Myers Patient Bristol-Myers Squibb India Pvt. Assistance Program Ltd.]) attracts 5% IGST under Schedule I of the GST notification.
The Basic Customs Duty (BCD) for HSN code 30069300 is 10%. On import, the landed duty also adds Social Welfare Surcharge (on BCD) and IGST (on the duty-inclusive value).
HSN code 30069300 covers Pharmaceutical Goods Specified in Note 4 to This Chapter — Placebos and blinded (or double-blinded) clinical trial kits for a recognised clinical trial, put up in measured doses DRUGS AND MEDICINES ARE SUPPLIED FREE OF COST TO THE PATIENTS UNDER THE PATIENT ASSISTANCE PROGRAMME OF THE SPECIFIED PHARMACEUTICAL COMPANY: [Notifn. No. 16/2017-Cus., dt. 20.4. 2017 as amended by 83/17, 41/20, 09/22, 07/24]. In exercise of the powers conferred by sub-section (1) of section 25 of the Customs Act, 1962 (52 of 1962), the Central Government, being satisfied that it is necessary in the public interest so to do, hereby exempts the goods, falling under Chapter 30 of the First Schedule to the Customs Tariff Act, 1975 (51 of 1975), of the description specified in column (2) of the Table below, for supply under Patient Assistance Programmes specified in the corresponding entry in column (3) of the said Table, run by the pharmaceutical companies specified in the corresponding entry in column (4) of the said Table, when imported into India, from the whole of the duty of customs leviable thereon which is specified in the First Schedule to the said Customs Tariff Act, subject to the following conditions, namely:- (a) the drugs and medicines are supplied free of cost to the patients under the Patient Assistance Programme of the specified pharmaceutical company; (b) the said pharmaceutical company furnishes an undertaking to the Assistant Commissioner of Customs or the Deputy Commissioner of Customs, as the case may be, having jurisdiction, to the effect that- (i) it shall maintain the following records:- (A) name, age, gender, residence and contact details of the patient; (B) copies of valid identity proof and residence proof of the patient and the caregiver, if any, as the case may be; (C) the disease diagnosed and the prescribed dosage of drugs and medicines; (D) the drugs and medicines imported or received and consumed under the said programme; (ii) the goods shall be used for the specified purpose only; (c) The said pharmaceutical company also furnishes an undertaking to the Assistant Commissioner of Customs or Deputy Commissioner of Customs, as the case may be, having jurisdiction, to pay, in the event of failure to comply with any of the aforesaid conditions, an amount equal to the duty leviable on such goods but for the exemption contained in this notification, along with the applicable interest thereon. TABLE Sr. Description of drug Name of Patient Name of No. / medicine Assistance Programme pharmaceutical company running Patient Assistance Programme 1. Xtandi (Enzulatamide) Xtandi Patient Assistance Programme Astellas Pharma India Pvt. Ltd. 2. Dasatinib (Sprycel) Sprycel Assistance Program Bristol Myers Squibb India Pvt. Ltd. 3. Nivolumab (Opdyta) OASIS Bristol Myers Squibb India Pvt. Ltd. 4. Halaven (Eribulin medylate) Hope to Her - Eisai Pharmaceuticals India Pvt. Soft Tissue Sarcoma free upto disease progression HELP - Eisai Pharmaceuticals India Pvt. All cycles free for below poverty Ltd. line patients 5. Zonegran (Zonisamide) - Livefree - 33% Eisai Pharmaceuticals India Pvt. for Epilespy Support to patients for extending Ltd. duration of treatment as this is a chronic therapy 6. Imbruvica 1+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 7. Zytiga 3+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 8. Velcade 1mg 3+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 9. Velcade 3.5 mg 1+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 10. Caelax 1+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 11. Dacogen 1+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 12. Yondelis 1+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 13. Simponi 1 vial free on 1st purchase Janssen India, Johnson & Johnson Pvt. Ltd. 14. Remicade 5+4 on 3 dose therapy, 6+6 on Janssen India, Johnson & 4 dose therapy Johnson Pvt. Ltd. 15. Invega all SKUs 1+1 PAP (Maintenance dosage) Janssen India, Johnson & Johnson Pvt. Ltd. 16. Imatinib (Glivec) Glivec NOA Program/ Glivec Novartis India Ltd. International PAP 17. Nilotinib (Tasigna) Win for Patients- Cancer Care/ Novartis Healthcare Private. Umaang Limited 18. Ruxolitinib (Jakavi) Win for Patients- Cancer Care/ Novartis Healthcare Private Umaang Limited 19. Everolimus (Afinitor) Win for Patients- Cancer Care/ Novartis Healthcare Private Umaang Limited 20. Ceritinib (Spexib) Win for Patients- Cancer Care/ Sandoz India Private Limited Umaang 21. Pazopanib (Votrient) Win for Patients- Cancer Care/ Novartis Healthcare Private Umaang Limited 22. Eltrombopag (Revolade) Win for Patients- Cancer Care/ Novartis Healthcare Private Umaang Limited 23. Indicaterol (Sequadra) Win for Patients - COPD Novartis India Ltd. 24. Secukinumab (Scapho) Win for Patients - Skincare Novartis India Ltd. 25. Omalizumab (Xolair CSU) Win for Patients - Skin care Novartis India Ltd. 26. Ranibizumab (Accentrix) Win for Patients - Visioncare Novartis India Ltd. 27. RITUXIMAB SPARSH - The Touch Dr. Reddy's Laboratories Ltd. 28. Erlotinib (Tarceva) The Blue Tree Roche Products (India) Private Limited 29. Trastuzumab (Herclon) The Blue Tree Roche Products (India) Private Limited 30. Pertuzumab (Perjeta) The Blue Tree Roche Products (India) Private Limited 31. Transtuzumab Emtansine The Blue Tree Roche Products (Kadcyla) (India) Private Limited 32. Obinutuzumab (Gazyva) The Blue Tree Roche Products (India) Private Limited 33. Bevacizumab (Avastin) The Blue Tree Roche Products (India) Private Limited 34. Tocilizumab (Actemra) Care for Joints Roche Products (India) Private Limited 35. Mycophenolate Aarambh Roche Products Mofetil (CellCept) (India) Private Limited 36. Avonex (Interferon Reach UCB India Private Limited Beta 1A) 37. Tysabri (Monoclonal Reach UCB India Private Limited Antibody 38. Tecfidera (Di-methyl Reach UCB India Private Limited Fumarate) 39. Plegridy (Peggylated Reach UCB India Private Limited Interferon Beta 1A) 40. Sorafenib (Nexavar) NexCSP (Nexavar Cancer Bayer ZydusPharma Private Survivorship Program) Limited 41. Sirturo (Bedaquiline) Bedaquiline Compassionate Janssen India, Johnson & Use Program Johnson Private Limited 42. Darzalex (Daratumumab) Daratumumab Patient Janssen India, Johnson & Assistance Program Johnson Private Limited 43. SUTENT Sutent Patient Assistance Programme - Pfizer Products India Private STAR Limited -Full subsidy for BPL patients 44. CRIZALK Crizalk Patient Assistance Programme- Pfizer Products India Private STAR Limited 45. INLYTA Inlyta Patient Assistance Programme - Pfizer Products India Private STAR Limited 46. PALBACE Palbace Patient Assistance Pfizer Products India Private Programme- PRERNA Limited 47. ENBREL Enbrel Patient Assistance Pfizer Limited 48. XELJANZ Xeljanz Patient Assistance Pfizer Limited 49. GENPTROPIN Genotropin Patient Assistance Pfizer Products India Private Programme Limited 50. Atgam Atgam Patient Assistance Programme Pfizer Products India Private Limited 51. Aromasin Aromasin Patient Assistance Pfizer Products India Private Programme Limited 52. Campto Campto Patient Assistance Programme Pfizer Products India Private Limited 1[53.Pembrolizumab Key- PAP 1.0 MSD Pharmaceuticals 54. Pembrolizumab KIRAN MSD Pharmaceuticals 55. Lorlatinib LorbriquaCare Pfizer Products India Private Ltd. 56. Dacomitinib DacoCare Pfizer Products India Private Ltd. 57. Inotuzumab Ozogamicin HemaCare Pfizer Products India Private Ltd. 58. Ribociclib UMAANG Novartis Healthcare Pvt. Ltd. 59. Dabrafenib UMAANG Novartis Healthcare Pvt. Ltd. 60. Selumetinib AstraZeneca Pharma PAP AstraZeneca Pharma India Limited 1 Inserted by Notification No. 09/2025 - Customs, dated 01.02.2025 w.e.f. 02.02.2025. 61. Benralizumab AstraZeneca Pharma PAP AstraZeneca Pharma India Limited 62. Fulvestrant AstraZeneca Pharma PAP AstraZeneca Pharma India Limited 63. Acalabrutinib AstraZeneca Pharma PAP AstraZeneca Pharma India Limited 64. Olaparib AstraZeneca Pharma PAP AstraZeneca Pharma India Limited 65. Amivantamab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 66. Teclistamab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 67. Ustekinumab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 68. Daratumumab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. And hyaluronidase-fihj 69. Ibrutinib Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 70. Bortezomib Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 71. Daratumumab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 72. Cetuximab Rainbow PAP Merck Specialties Pvt. Ltd. 73. Avelumab My Bavencio Assist Merck Specialties Pvt. Ltd. Program 74. Tepotinib My Tepmetko Patient Access Merck Specialties Pvt. Ltd. Program 75. Brentuximab Vedotin Takeda PAP Takeda Biopharmaceuticals India Pvt. Limited 76. Vedolizumab Takeda PAP Takeda Biopharmaceuticals India Pvt. Limited 77. Velaglucerase Alpha Takeda PAP Takeda Biopharmaceuticals India Pvt. Limited 78. Agalsidase Alpha Takeda PAP Takeda Biopharmaceuticals India Pvt. Limited 79. Idursulphase Takeda PAP Takeda Biopharmaceuticals India Pvt. Limited 80. Mepolizumab GSK Pharmaceuticals Limited GSK Pharmaceuticals Limited 81. Alectinib The Blue Tree Roche Products India Private Ltd. 82. Risdiplam Powder The Blue Tree Roche Products India Private Ltd. 83. Emicizumab The Blue Tree Roche Products India Private Ltd. 84. Atezolizumab The Blue Tree Roche Products India Private Ltd. 85. Pertuzumab + The Blue Tree Roche Products India Private trastuzumab Ltd. 86. Ocrelizumab The Blue Tree Roche Products India Private Ltd. 87. Polatuzumab vedotin The Blue Tree Roche Products India Private Ltd. 88. Faricimab The Blue Tree Roche Products India Private Ltd. 89. Luspatercept Bristol-Myers Patient Bristol-Myers Squibb India Pvt. Assistance Program Ltd.]. It sits under Chapter 30 – Pharmaceutical products, in Section VI – PRODUCTS OF THE CHEMICAL OR ALLIED INDUSTRIES.
The HSN code for Pharmaceutical Goods Specified in Note 4 to This Chapter — Placebos and blinded (or double-blinded) clinical trial kits for a recognised clinical trial, put up in measured doses DRUGS AND MEDICINES ARE SUPPLIED FREE OF COST TO THE PATIENTS UNDER THE PATIENT ASSISTANCE PROGRAMME OF THE SPECIFIED PHARMACEUTICAL COMPANY: [Notifn. No. 16/2017-Cus., dt. 20.4. 2017 as amended by 83/17, 41/20, 09/22, 07/24]. In exercise of the powers conferred by sub-section (1) of section 25 of the Customs Act, 1962 (52 of 1962), the Central Government, being satisfied that it is necessary in the public interest so to do, hereby exempts the goods, falling under Chapter 30 of the First Schedule to the Customs Tariff Act, 1975 (51 of 1975), of the description specified in column (2) of the Table below, for supply under Patient Assistance Programmes specified in the corresponding entry in column (3) of the said Table, run by the pharmaceutical companies specified in the corresponding entry in column (4) of the said Table, when imported into India, from the whole of the duty of customs leviable thereon which is specified in the First Schedule to the said Customs Tariff Act, subject to the following conditions, namely:- (a) the drugs and medicines are supplied free of cost to the patients under the Patient Assistance Programme of the specified pharmaceutical company; (b) the said pharmaceutical company furnishes an undertaking to the Assistant Commissioner of Customs or the Deputy Commissioner of Customs, as the case may be, having jurisdiction, to the effect that- (i) it shall maintain the following records:- (A) name, age, gender, residence and contact details of the patient; (B) copies of valid identity proof and residence proof of the patient and the caregiver, if any, as the case may be; (C) the disease diagnosed and the prescribed dosage of drugs and medicines; (D) the drugs and medicines imported or received and consumed under the said programme; (ii) the goods shall be used for the specified purpose only; (c) The said pharmaceutical company also furnishes an undertaking to the Assistant Commissioner of Customs or Deputy Commissioner of Customs, as the case may be, having jurisdiction, to pay, in the event of failure to comply with any of the aforesaid conditions, an amount equal to the duty leviable on such goods but for the exemption contained in this notification, along with the applicable interest thereon. TABLE Sr. Description of drug Name of Patient Name of No. / medicine Assistance Programme pharmaceutical company running Patient Assistance Programme 1. Xtandi (Enzulatamide) Xtandi Patient Assistance Programme Astellas Pharma India Pvt. Ltd. 2. Dasatinib (Sprycel) Sprycel Assistance Program Bristol Myers Squibb India Pvt. Ltd. 3. Nivolumab (Opdyta) OASIS Bristol Myers Squibb India Pvt. Ltd. 4. Halaven (Eribulin medylate) Hope to Her - Eisai Pharmaceuticals India Pvt. Soft Tissue Sarcoma free upto disease progression HELP - Eisai Pharmaceuticals India Pvt. All cycles free for below poverty Ltd. line patients 5. Zonegran (Zonisamide) - Livefree - 33% Eisai Pharmaceuticals India Pvt. for Epilespy Support to patients for extending Ltd. duration of treatment as this is a chronic therapy 6. Imbruvica 1+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 7. Zytiga 3+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 8. Velcade 1mg 3+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 9. Velcade 3.5 mg 1+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 10. Caelax 1+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 11. Dacogen 1+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 12. Yondelis 1+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 13. Simponi 1 vial free on 1st purchase Janssen India, Johnson & Johnson Pvt. Ltd. 14. Remicade 5+4 on 3 dose therapy, 6+6 on Janssen India, Johnson & 4 dose therapy Johnson Pvt. Ltd. 15. Invega all SKUs 1+1 PAP (Maintenance dosage) Janssen India, Johnson & Johnson Pvt. Ltd. 16. Imatinib (Glivec) Glivec NOA Program/ Glivec Novartis India Ltd. International PAP 17. Nilotinib (Tasigna) Win for Patients- Cancer Care/ Novartis Healthcare Private. Umaang Limited 18. Ruxolitinib (Jakavi) Win for Patients- Cancer Care/ Novartis Healthcare Private Umaang Limited 19. Everolimus (Afinitor) Win for Patients- Cancer Care/ Novartis Healthcare Private Umaang Limited 20. Ceritinib (Spexib) Win for Patients- Cancer Care/ Sandoz India Private Limited Umaang 21. Pazopanib (Votrient) Win for Patients- Cancer Care/ Novartis Healthcare Private Umaang Limited 22. Eltrombopag (Revolade) Win for Patients- Cancer Care/ Novartis Healthcare Private Umaang Limited 23. Indicaterol (Sequadra) Win for Patients - COPD Novartis India Ltd. 24. Secukinumab (Scapho) Win for Patients - Skincare Novartis India Ltd. 25. Omalizumab (Xolair CSU) Win for Patients - Skin care Novartis India Ltd. 26. Ranibizumab (Accentrix) Win for Patients - Visioncare Novartis India Ltd. 27. RITUXIMAB SPARSH - The Touch Dr. Reddy's Laboratories Ltd. 28. Erlotinib (Tarceva) The Blue Tree Roche Products (India) Private Limited 29. Trastuzumab (Herclon) The Blue Tree Roche Products (India) Private Limited 30. Pertuzumab (Perjeta) The Blue Tree Roche Products (India) Private Limited 31. Transtuzumab Emtansine The Blue Tree Roche Products (Kadcyla) (India) Private Limited 32. Obinutuzumab (Gazyva) The Blue Tree Roche Products (India) Private Limited 33. Bevacizumab (Avastin) The Blue Tree Roche Products (India) Private Limited 34. Tocilizumab (Actemra) Care for Joints Roche Products (India) Private Limited 35. Mycophenolate Aarambh Roche Products Mofetil (CellCept) (India) Private Limited 36. Avonex (Interferon Reach UCB India Private Limited Beta 1A) 37. Tysabri (Monoclonal Reach UCB India Private Limited Antibody 38. Tecfidera (Di-methyl Reach UCB India Private Limited Fumarate) 39. Plegridy (Peggylated Reach UCB India Private Limited Interferon Beta 1A) 40. Sorafenib (Nexavar) NexCSP (Nexavar Cancer Bayer ZydusPharma Private Survivorship Program) Limited 41. Sirturo (Bedaquiline) Bedaquiline Compassionate Janssen India, Johnson & Use Program Johnson Private Limited 42. Darzalex (Daratumumab) Daratumumab Patient Janssen India, Johnson & Assistance Program Johnson Private Limited 43. SUTENT Sutent Patient Assistance Programme - Pfizer Products India Private STAR Limited -Full subsidy for BPL patients 44. CRIZALK Crizalk Patient Assistance Programme- Pfizer Products India Private STAR Limited 45. INLYTA Inlyta Patient Assistance Programme - Pfizer Products India Private STAR Limited 46. PALBACE Palbace Patient Assistance Pfizer Products India Private Programme- PRERNA Limited 47. ENBREL Enbrel Patient Assistance Pfizer Limited 48. XELJANZ Xeljanz Patient Assistance Pfizer Limited 49. GENPTROPIN Genotropin Patient Assistance Pfizer Products India Private Programme Limited 50. Atgam Atgam Patient Assistance Programme Pfizer Products India Private Limited 51. Aromasin Aromasin Patient Assistance Pfizer Products India Private Programme Limited 52. Campto Campto Patient Assistance Programme Pfizer Products India Private Limited 1[53.Pembrolizumab Key- PAP 1.0 MSD Pharmaceuticals 54. Pembrolizumab KIRAN MSD Pharmaceuticals 55. Lorlatinib LorbriquaCare Pfizer Products India Private Ltd. 56. Dacomitinib DacoCare Pfizer Products India Private Ltd. 57. Inotuzumab Ozogamicin HemaCare Pfizer Products India Private Ltd. 58. Ribociclib UMAANG Novartis Healthcare Pvt. Ltd. 59. Dabrafenib UMAANG Novartis Healthcare Pvt. Ltd. 60. Selumetinib AstraZeneca Pharma PAP AstraZeneca Pharma India Limited 1 Inserted by Notification No. 09/2025 - Customs, dated 01.02.2025 w.e.f. 02.02.2025. 61. Benralizumab AstraZeneca Pharma PAP AstraZeneca Pharma India Limited 62. Fulvestrant AstraZeneca Pharma PAP AstraZeneca Pharma India Limited 63. Acalabrutinib AstraZeneca Pharma PAP AstraZeneca Pharma India Limited 64. Olaparib AstraZeneca Pharma PAP AstraZeneca Pharma India Limited 65. Amivantamab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 66. Teclistamab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 67. Ustekinumab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 68. Daratumumab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. And hyaluronidase-fihj 69. Ibrutinib Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 70. Bortezomib Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 71. Daratumumab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 72. Cetuximab Rainbow PAP Merck Specialties Pvt. Ltd. 73. Avelumab My Bavencio Assist Merck Specialties Pvt. Ltd. Program 74. Tepotinib My Tepmetko Patient Access Merck Specialties Pvt. Ltd. Program 75. Brentuximab Vedotin Takeda PAP Takeda Biopharmaceuticals India Pvt. Limited 76. Vedolizumab Takeda PAP Takeda Biopharmaceuticals India Pvt. Limited 77. Velaglucerase Alpha Takeda PAP Takeda Biopharmaceuticals India Pvt. Limited 78. Agalsidase Alpha Takeda PAP Takeda Biopharmaceuticals India Pvt. Limited 79. Idursulphase Takeda PAP Takeda Biopharmaceuticals India Pvt. Limited 80. Mepolizumab GSK Pharmaceuticals Limited GSK Pharmaceuticals Limited 81. Alectinib The Blue Tree Roche Products India Private Ltd. 82. Risdiplam Powder The Blue Tree Roche Products India Private Ltd. 83. Emicizumab The Blue Tree Roche Products India Private Ltd. 84. Atezolizumab The Blue Tree Roche Products India Private Ltd. 85. Pertuzumab + The Blue Tree Roche Products India Private trastuzumab Ltd. 86. Ocrelizumab The Blue Tree Roche Products India Private Ltd. 87. Polatuzumab vedotin The Blue Tree Roche Products India Private Ltd. 88. Faricimab The Blue Tree Roche Products India Private Ltd. 89. Luspatercept Bristol-Myers Patient Bristol-Myers Squibb India Pvt. Assistance Program Ltd.] is 30069300, classified under Chapter 30 – Pharmaceutical products of India's Customs Tariff (ITC-HS).
The standard unit of quantity (UQC) for HSN code 30069300 is kg, as listed in the Customs Tariff.
Still have questions? Our support team is here to help 24/7.